Quarterly Result13 Feb 2026, 04:01 pm
Medicamen Biotech Ltd. Announces Unaudited Financial Results for Q3 2025
AI Summary
Medicamen Biotech Ltd. has announced its unaudited financial results for the quarter ended on December 31, 2025. The company's revenue for the quarter stands at 4,349.07, with a net profit of 218.72. The company operates only in the pharmaceuticals formulations business segment. The financial results have been reviewed by the Audit Committee and approved by the Board of Directors.
Key Highlights
- Revenue for the quarter ended on December 31, 2025, stands at 4,349.07
- Net profit for the quarter is 218.72
- The company operates only in the pharmaceuticals formulations business segment
- Financial results have been reviewed by the Audit Committee
- Financial results have been approved by the Board of Directors
Price Impact
More from MEDICAMEQ